| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | serine-type peptidase activity | KLK15 TPSAB1 PRSS29P RELN TMPRSS6 GZMM KLK12 HABP2 KLK5 PRSS58 TPSB2 | 1.60e-09 | 207 | 87 | 11 | GO:0008236 |
| GeneOntologyMolecularFunction | serine hydrolase activity | KLK15 TPSAB1 PRSS29P RELN TMPRSS6 GZMM KLK12 HABP2 KLK5 PRSS58 TPSB2 | 2.06e-09 | 212 | 87 | 11 | GO:0017171 |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | KLK15 TPSAB1 PRSS29P TMPRSS6 GZMM KLK12 HABP2 KLK5 PRSS58 TPSB2 | 1.02e-08 | 190 | 87 | 10 | GO:0004252 |
| GeneOntologyMolecularFunction | TAP complex binding | 4.17e-08 | 9 | 87 | 4 | GO:0062061 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 4.17e-08 | 9 | 87 | 4 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP1 binding | 6.92e-08 | 10 | 87 | 4 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 6.92e-08 | 10 | 87 | 4 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 6.92e-08 | 10 | 87 | 4 | GO:0046977 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 1.62e-07 | 12 | 87 | 4 | GO:0030881 | |
| GeneOntologyMolecularFunction | endopeptidase activity | KLK15 TPSAB1 PRSS29P ADAM15 TMPRSS6 GZMM KLK12 HABP2 KLK5 PRSS58 CTSD TPSB2 | 3.52e-07 | 430 | 87 | 12 | GO:0004175 |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 7.66e-07 | 17 | 87 | 4 | GO:0046703 | |
| GeneOntologyMolecularFunction | peptidase activity | KLK15 TPSAB1 PRSS29P RELN ADAM15 UNC5CL TMPRSS6 GZMM KLK12 HABP2 KLK5 PRSS58 CTSD TPSB2 | 8.47e-07 | 654 | 87 | 14 | GO:0008233 |
| GeneOntologyMolecularFunction | T cell receptor binding | 1.54e-06 | 20 | 87 | 4 | GO:0042608 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 1.10e-05 | 32 | 87 | 4 | GO:0042288 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 3.32e-05 | 42 | 87 | 4 | GO:0071889 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 6.13e-05 | 49 | 87 | 4 | GO:0042605 | |
| GeneOntologyMolecularFunction | MHC protein binding | 1.19e-04 | 58 | 87 | 4 | GO:0042287 | |
| GeneOntologyMolecularFunction | peptide binding | 4.78e-04 | 318 | 87 | 7 | GO:0042277 | |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 6.95e-04 | 161 | 87 | 5 | GO:0051087 | |
| GeneOntologyMolecularFunction | cGMP binding | 2.16e-03 | 16 | 87 | 2 | GO:0030553 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 1.60e-08 | 8 | 82 | 4 | GO:0002485 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 4.07e-07 | 16 | 82 | 4 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 5.31e-07 | 17 | 82 | 4 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 5.31e-07 | 17 | 82 | 4 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 6.80e-07 | 18 | 82 | 4 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 6.80e-07 | 18 | 82 | 4 | GO:0042590 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 1.31e-06 | 48 | 82 | 5 | GO:0002478 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.94e-06 | 23 | 82 | 4 | GO:0019885 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 2.75e-06 | 25 | 82 | 4 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 2.75e-06 | 25 | 82 | 4 | GO:0002475 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 3.41e-06 | 58 | 82 | 5 | GO:0019884 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 7.66e-06 | 32 | 82 | 4 | GO:0019883 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 8.68e-06 | 70 | 82 | 5 | GO:0001913 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 1.30e-05 | 76 | 82 | 5 | GO:0048002 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 1.93e-05 | 139 | 82 | 6 | GO:0019882 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 2.10e-05 | 41 | 82 | 4 | GO:0002474 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 2.31e-05 | 42 | 82 | 4 | GO:0001916 | |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 4.74e-05 | 163 | 82 | 6 | GO:0002456 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 5.79e-05 | 169 | 82 | 6 | GO:0010977 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 5.86e-05 | 53 | 82 | 4 | GO:0001914 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 6.04e-05 | 249 | 82 | 7 | GO:0035264 | |
| GeneOntologyBiologicalProcess | detection of bacterium | 6.58e-05 | 20 | 82 | 3 | GO:0016045 | |
| GeneOntologyBiologicalProcess | inner ear development | 6.68e-05 | 253 | 82 | 7 | GO:0048839 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | 8.09e-05 | 111 | 82 | 5 | GO:0002709 | |
| GeneOntologyBiologicalProcess | regulation of inorganic anion transmembrane transport | 9.32e-05 | 4 | 82 | 2 | GO:1903795 | |
| GeneOntologyBiologicalProcess | detection of other organism | 1.01e-04 | 23 | 82 | 3 | GO:0098543 | |
| GeneOntologyBiologicalProcess | ear development | 1.40e-04 | 285 | 82 | 7 | GO:0043583 | |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 1.47e-04 | 26 | 82 | 3 | GO:1900424 | |
| GeneOntologyBiologicalProcess | positive regulation of antibacterial peptide production | 1.55e-04 | 5 | 82 | 2 | GO:0002803 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 2.16e-04 | 74 | 82 | 4 | GO:0002711 | |
| GeneOntologyBiologicalProcess | extracellular matrix disassembly | 2.28e-04 | 75 | 82 | 4 | GO:0022617 | |
| GeneOntologyBiologicalProcess | positive regulation of immune effector process | 2.69e-04 | 317 | 82 | 7 | GO:0002699 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 2.78e-04 | 79 | 82 | 4 | GO:0001912 | |
| GeneOntologyBiologicalProcess | detection of external biotic stimulus | 3.03e-04 | 33 | 82 | 3 | GO:0098581 | |
| GeneOntologyBiologicalProcess | positive regulation of antimicrobial peptide production | 3.24e-04 | 7 | 82 | 2 | GO:0002225 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 3.31e-04 | 150 | 82 | 5 | GO:0002708 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 3.31e-04 | 150 | 82 | 5 | GO:0002824 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 3.33e-04 | 233 | 82 | 6 | GO:0031345 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 4.20e-04 | 88 | 82 | 4 | GO:0031343 | |
| GeneOntologyBiologicalProcess | positive regulation of antimicrobial humoral response | 4.30e-04 | 8 | 82 | 2 | GO:0002760 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response | 4.32e-04 | 159 | 82 | 5 | GO:0002821 | |
| GeneOntologyBiologicalProcess | protection from natural killer cell mediated cytotoxicity | 5.52e-04 | 9 | 82 | 2 | GO:0042270 | |
| GeneOntologyBiologicalProcess | macrophage inflammatory protein-1 alpha production | 5.52e-04 | 9 | 82 | 2 | GO:0071608 | |
| GeneOntologyBiologicalProcess | regulation of antibacterial peptide production | 5.52e-04 | 9 | 82 | 2 | GO:0002786 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated immunity | 6.69e-04 | 175 | 82 | 5 | GO:0002705 | |
| GeneOntologyBiologicalProcess | positive regulation of G protein-coupled receptor signaling pathway | 7.13e-04 | 44 | 82 | 3 | GO:0045745 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 7.17e-04 | 612 | 82 | 9 | GO:0010975 | |
| GeneOntologyBiologicalProcess | regulation of immune effector process | 8.04e-04 | 497 | 82 | 8 | GO:0002697 | |
| GeneOntologyBiologicalProcess | detection of biotic stimulus | 8.13e-04 | 46 | 82 | 3 | GO:0009595 | |
| GeneOntologyBiologicalProcess | cellular response to phorbol 13-acetate 12-myristate | 8.39e-04 | 11 | 82 | 2 | GO:1904628 | |
| GeneOntologyBiologicalProcess | response to phorbol 13-acetate 12-myristate | 8.39e-04 | 11 | 82 | 2 | GO:1904627 | |
| GeneOntologyBiologicalProcess | regulation of antimicrobial peptide production | 8.39e-04 | 11 | 82 | 2 | GO:0002784 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 9.01e-04 | 187 | 82 | 5 | GO:0001909 | |
| GeneOntologyBiologicalProcess | antibacterial peptide production | 1.00e-03 | 12 | 82 | 2 | GO:0002778 | |
| GeneOntologyBiologicalProcess | multi-organism reproductive process | 1.05e-03 | 290 | 82 | 6 | GO:0044703 | |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 1.13e-03 | 294 | 82 | 6 | GO:0044706 | |
| GeneOntologyBiologicalProcess | defense response to bacterium | 1.15e-03 | 405 | 82 | 7 | GO:0042742 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 1.02e-08 | 7 | 88 | 4 | GO:0032398 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 6.04e-08 | 10 | 88 | 4 | GO:0042612 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 2.84e-07 | 14 | 88 | 4 | GO:0042824 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 6.69e-07 | 17 | 88 | 4 | GO:0033106 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 2.44e-06 | 23 | 88 | 4 | GO:0005797 | |
| GeneOntologyCellularComponent | MHC protein complex | 4.08e-06 | 26 | 88 | 4 | GO:0042611 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 7.39e-06 | 64 | 88 | 5 | GO:0012507 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 1.39e-05 | 35 | 88 | 4 | GO:0098553 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 2.90e-05 | 42 | 88 | 4 | GO:0070971 | |
| GeneOntologyCellularComponent | cis-Golgi network | 2.97e-05 | 85 | 88 | 5 | GO:0005801 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 4.55e-05 | 47 | 88 | 4 | GO:0031462 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 4.95e-05 | 48 | 88 | 4 | GO:0098576 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 5.32e-05 | 157 | 88 | 6 | GO:0045335 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 1.02e-04 | 110 | 88 | 5 | GO:0030134 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 1.86e-04 | 125 | 88 | 5 | GO:0140534 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 2.97e-04 | 215 | 88 | 6 | GO:0030662 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 4.18e-04 | 83 | 88 | 4 | GO:0030670 | |
| GeneOntologyCellularComponent | endocytic vesicle | 1.18e-03 | 384 | 88 | 7 | GO:0030139 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 1.29e-03 | 112 | 88 | 4 | GO:0055038 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 1.49e-03 | 293 | 88 | 6 | GO:0030658 | |
| GeneOntologyCellularComponent | early endosome membrane | 2.03e-03 | 212 | 88 | 5 | GO:0031901 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 2.03e-03 | 212 | 88 | 5 | GO:0030666 | |
| GeneOntologyCellularComponent | Golgi cisterna | 2.55e-03 | 135 | 88 | 4 | GO:0031985 | |
| GeneOntologyCellularComponent | photoreceptor outer segment membrane | 2.86e-03 | 19 | 88 | 2 | GO:0042622 | |
| GeneOntologyCellularComponent | Golgi membrane | 3.31e-03 | 721 | 88 | 9 | GO:0000139 | |
| GeneOntologyCellularComponent | lysosomal membrane | 3.35e-03 | 462 | 88 | 7 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 3.35e-03 | 462 | 88 | 7 | GO:0098852 | |
| GeneOntologyCellularComponent | coated vesicle | 4.15e-03 | 360 | 88 | 6 | GO:0030135 | |
| GeneOntologyCellularComponent | membrane raft | 4.26e-03 | 362 | 88 | 6 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 4.38e-03 | 364 | 88 | 6 | GO:0098857 | |
| GeneOntologyCellularComponent | vacuolar membrane | 5.55e-03 | 507 | 88 | 7 | GO:0005774 | |
| GeneOntologyCellularComponent | Golgi stack | 5.91e-03 | 171 | 88 | 4 | GO:0005795 | |
| MousePheno | spinal cord inflammation | 2.76e-08 | 8 | 64 | 4 | MP:0030987 | |
| MousePheno | increased NK cell number | 1.93e-06 | 82 | 64 | 6 | MP:0008044 | |
| MousePheno | abnormal mature NK cell number | 3.96e-06 | 24 | 64 | 4 | MP:0013671 | |
| MousePheno | abnormal mature NK cell morphology | 4.70e-06 | 25 | 64 | 4 | MP:0013700 | |
| MousePheno | increased alpha-beta T cell number | 1.12e-05 | 311 | 64 | 9 | MP:0012764 | |
| MousePheno | increased CD4-positive, alpha-beta T cell number | 1.34e-05 | 241 | 64 | 8 | MP:0008074 | |
| MousePheno | decreased NK cell number | 1.76e-05 | 120 | 64 | 6 | MP:0008045 | |
| MousePheno | decreased immature NK cell number | 3.21e-05 | 14 | 64 | 3 | MP:0013666 | |
| MousePheno | demyelination | 4.25e-05 | 85 | 64 | 5 | MP:0000921 | |
| MousePheno | decreased susceptibility to autoimmune diabetes | 5.17e-05 | 45 | 64 | 4 | MP:0004804 | |
| MousePheno | decreased CD8-positive, alpha-beta T cell number | 5.95e-05 | 218 | 64 | 7 | MP:0008079 | |
| MousePheno | decreased gamma-delta T cell number | 6.15e-05 | 47 | 64 | 4 | MP:0008347 | |
| MousePheno | decreased mature NK cell number | 7.11e-05 | 18 | 64 | 3 | MP:0013672 | |
| MousePheno | decreased splenocyte proliferation | 8.42e-05 | 19 | 64 | 3 | MP:0009335 | |
| MousePheno | abnormal immature NK cell number | 8.42e-05 | 19 | 64 | 3 | MP:0013665 | |
| MousePheno | abnormal immature NK cell morphology | 8.42e-05 | 19 | 64 | 3 | MP:0013699 | |
| MousePheno | decreased alpha-beta T cell number | 8.99e-05 | 315 | 64 | 8 | MP:0012765 | |
| MousePheno | CNS inflammation | 1.06e-04 | 54 | 64 | 4 | MP:0006082 | |
| MousePheno | abnormal NK cell number | 1.32e-04 | 172 | 64 | 6 | MP:0008043 | |
| MousePheno | cystolithiasis | 1.32e-04 | 22 | 64 | 3 | MP:0011625 | |
| MousePheno | abnormal alpha-beta T cell morphology | GADD45B HLA-A HLA-B HLA-C MTOR TMPRSS6 HLA-H PRKDC CTSD TMEM127 NOD2 | 1.38e-04 | 640 | 64 | 11 | MP:0012762 |
| MousePheno | abnormal CD4-positive, alpha beta T cell morphology | 1.57e-04 | 437 | 64 | 9 | MP:0002432 | |
| MousePheno | decreased susceptibility to autoimmune disorder | 1.69e-04 | 180 | 64 | 6 | MP:0005351 | |
| MousePheno | abnormal NK cell morphology | 1.85e-04 | 183 | 64 | 6 | MP:0005068 | |
| MousePheno | abnormal CD8-positive, alpha-beta T cell number | 1.93e-04 | 352 | 64 | 8 | MP:0008077 | |
| MousePheno | increased cellular sensitivity to X-ray irradiation | 2.05e-04 | 5 | 64 | 2 | MP:0002879 | |
| MousePheno | decreased T cell number | HLA-A HLA-B HLA-C APEX2 MTOR TMPRSS6 HLA-H PRKDC CTSD TMEM127 | 2.30e-04 | 566 | 64 | 10 | MP:0005018 |
| MousePheno | abnormal gamma-delta T cell number | 2.76e-04 | 69 | 64 | 4 | MP:0008345 | |
| MousePheno | increased T cell number | 2.93e-04 | 475 | 64 | 9 | MP:0005015 | |
| MousePheno | abnormal CD8-positive, alpha beta T cell morphology | 3.19e-04 | 379 | 64 | 8 | MP:0005010 | |
| MousePheno | urolithiasis | 3.75e-04 | 31 | 64 | 3 | MP:0005360 | |
| MousePheno | abnormal CD4-positive, alpha-beta T cell number | 3.92e-04 | 391 | 64 | 8 | MP:0008073 | |
| MousePheno | abnormal gamma-delta T cell morphology | 4.42e-04 | 78 | 64 | 4 | MP:0008343 | |
| MousePheno | abnormal splenocyte proliferation | 4.53e-04 | 33 | 64 | 3 | MP:0009334 | |
| MousePheno | abnormal susceptibility to autoimmune disorder | 4.89e-04 | 307 | 64 | 7 | MP:0002425 | |
| MousePheno | abnormal effector T cell morphology | GADD45B HLA-A HLA-B HLA-C MTOR TMPRSS6 HLA-H PRKDC TMEM127 NOD2 | 5.33e-04 | 629 | 64 | 10 | MP:0002435 |
| MousePheno | abnormal T cell morphology | GADD45B HLA-A HLA-B HLA-C APEX2 MTOR TMPRSS6 HLA-H PRKDC CTSD TMEM127 NOD2 | 5.53e-04 | 878 | 64 | 12 | MP:0008037 |
| MousePheno | abnormal alpha-beta T cell number | 7.62e-04 | 542 | 64 | 9 | MP:0012763 | |
| MousePheno | abnormal myelination | 9.63e-04 | 166 | 64 | 5 | MP:0000920 | |
| MousePheno | abnormal T cell number | HLA-A HLA-B HLA-C APEX2 MTOR TMPRSS6 HLA-H PRKDC CTSD TMEM127 NOD2 | 1.11e-03 | 818 | 64 | 11 | MP:0006387 |
| MousePheno | lethality at weaning, complete penetrance | 1.21e-03 | 46 | 64 | 3 | MP:0011083 | |
| MousePheno | abnormal T cell physiology | 1.29e-03 | 584 | 64 | 9 | MP:0002444 | |
| MousePheno | abnormal B cell migration | 1.32e-03 | 12 | 64 | 2 | MP:0014470 | |
| Domain | TRYPSIN_HIS | 8.64e-10 | 103 | 84 | 9 | IPR018114 | |
| Domain | TRYPSIN_SER | 1.12e-09 | 106 | 84 | 9 | PS00135 | |
| Domain | TRYPSIN_HIS | 1.22e-09 | 107 | 84 | 9 | PS00134 | |
| Domain | Peptidase_S1A | 1.98e-09 | 113 | 84 | 9 | IPR001314 | |
| Domain | TRYPSIN_DOM | 2.32e-09 | 115 | 84 | 9 | PS50240 | |
| Domain | Tryp_SPc | 2.70e-09 | 117 | 84 | 9 | SM00020 | |
| Domain | Trypsin | 3.64e-09 | 121 | 84 | 9 | PF00089 | |
| Domain | Trypsin_dom | 3.64e-09 | 121 | 84 | 9 | IPR001254 | |
| Domain | Peptidase_S1_PA | 4.21e-09 | 123 | 84 | 9 | IPR009003 | |
| Domain | MHC_I_a_C | 5.67e-09 | 6 | 84 | 4 | IPR010579 | |
| Domain | MHC_I_C | 5.67e-09 | 6 | 84 | 4 | PF06623 | |
| Domain | TRYPSIN_SER | 1.60e-07 | 90 | 84 | 7 | IPR033116 | |
| Domain | MHC_I | 2.15e-06 | 21 | 84 | 4 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 2.15e-06 | 21 | 84 | 4 | IPR001039 | |
| Domain | Znf_SWIM | 7.23e-06 | 9 | 84 | 3 | IPR007527 | |
| Domain | ZF_SWIM | 7.23e-06 | 9 | 84 | 3 | PS50966 | |
| Domain | - | 2.00e-05 | 2 | 84 | 2 | 4.10.1120.10 | |
| Domain | PDE6_gamma | 2.00e-05 | 2 | 84 | 2 | PF04868 | |
| Domain | PDE6_gamma | 2.00e-05 | 2 | 84 | 2 | IPR006952 | |
| Domain | C1-set | 1.01e-04 | 54 | 84 | 4 | PF07654 | |
| Domain | IGc1 | 1.17e-04 | 56 | 84 | 4 | SM00407 | |
| Domain | Ig_C1-set | 1.34e-04 | 58 | 84 | 4 | IPR003597 | |
| Domain | Ig/MHC_CS | 1.34e-04 | 58 | 84 | 4 | IPR003006 | |
| Domain | IG_MHC | 1.53e-04 | 60 | 84 | 4 | PS00290 | |
| Domain | - | 1.66e-04 | 24 | 84 | 3 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 1.66e-04 | 24 | 84 | 3 | IPR011161 | |
| Domain | FATC | 1.98e-04 | 5 | 84 | 2 | PF02260 | |
| Domain | FAT | 2.96e-04 | 6 | 84 | 2 | PS51189 | |
| Domain | FATC | 2.96e-04 | 6 | 84 | 2 | PS51190 | |
| Domain | FAT | 2.96e-04 | 6 | 84 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 2.96e-04 | 6 | 84 | 2 | IPR003151 | |
| Domain | FATC_dom | 2.96e-04 | 6 | 84 | 2 | IPR003152 | |
| Domain | PIK_FAT | 2.96e-04 | 6 | 84 | 2 | IPR014009 | |
| Domain | FATC | 2.96e-04 | 6 | 84 | 2 | SM01343 | |
| Domain | - | 3.96e-04 | 32 | 84 | 3 | 3.40.1110.10 | |
| Domain | - | 3.96e-04 | 32 | 84 | 3 | 2.70.150.10 | |
| Domain | SWIM | 4.14e-04 | 7 | 84 | 2 | PF04434 | |
| Domain | ATPase_P-typ_cyto_domN | 5.18e-04 | 35 | 84 | 3 | IPR023299 | |
| Domain | P_typ_ATPase | 5.63e-04 | 36 | 84 | 3 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 5.63e-04 | 36 | 84 | 3 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 5.63e-04 | 36 | 84 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 6.11e-04 | 37 | 84 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 6.11e-04 | 37 | 84 | 3 | PF00122 | |
| Domain | MHC_I/II-like_Ag-recog | 6.61e-04 | 38 | 84 | 3 | IPR011162 | |
| Domain | PI3/4_kinase_CS | 2.02e-03 | 15 | 84 | 2 | IPR018936 | |
| Domain | - | 2.30e-03 | 16 | 84 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 2.30e-03 | 16 | 84 | 2 | SM00146 | |
| Domain | PI3/4_kinase_cat_dom | 2.92e-03 | 18 | 84 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 2.92e-03 | 18 | 84 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 2.92e-03 | 18 | 84 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 2.92e-03 | 18 | 84 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 2.92e-03 | 18 | 84 | 2 | PS00916 | |
| Domain | Apc4_WD40_dom | 3.60e-03 | 20 | 84 | 2 | IPR024977 | |
| Domain | ANAPC4_WD40 | 3.60e-03 | 20 | 84 | 2 | PF12894 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 3.20e-08 | 9 | 58 | 4 | MM14527 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 7.56e-07 | 18 | 58 | 4 | MM14525 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 1.19e-06 | 20 | 58 | 4 | MM1374 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.31e-06 | 6 | 58 | 3 | M47468 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 2.29e-06 | 7 | 58 | 3 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 2.29e-06 | 7 | 58 | 3 | M47530 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 3.06e-06 | 25 | 58 | 4 | MM15713 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 3.06e-06 | 25 | 58 | 4 | MM1465 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 1.07e-05 | 11 | 58 | 3 | M525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.42e-05 | 12 | 58 | 3 | M47529 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 7.00e-05 | 54 | 58 | 4 | MM14871 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 8.08e-05 | 56 | 58 | 4 | MM15901 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 1.20e-04 | 62 | 58 | 4 | M39639 | |
| Pathway | PID_IL12_2PATHWAY | 1.20e-04 | 62 | 58 | 4 | M54 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 2.24e-04 | 29 | 58 | 3 | M1062 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 2.65e-04 | 76 | 58 | 4 | MM14526 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 2.93e-04 | 78 | 58 | 4 | M973 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 4.65e-04 | 37 | 58 | 3 | M18615 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 6.31e-04 | 41 | 58 | 3 | M13519 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 6.99e-04 | 98 | 58 | 4 | M965 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 7.26e-04 | 43 | 58 | 3 | M12617 | |
| Pathway | WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS | 1.07e-03 | 12 | 58 | 2 | MM15927 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.23e-03 | 114 | 58 | 4 | MM14571 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 1.27e-03 | 52 | 58 | 3 | M13103 | |
| Pathway | WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS | 1.47e-03 | 14 | 58 | 2 | M45553 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 1.49e-03 | 204 | 58 | 5 | M45011 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 1.49e-03 | 55 | 58 | 3 | M39763 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.49e-03 | 55 | 58 | 3 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.65e-03 | 57 | 58 | 3 | MM15643 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 1.69e-03 | 15 | 58 | 2 | M47663 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 1.78e-03 | 126 | 58 | 4 | M45009 | |
| Pubmed | 2.44e-11 | 10 | 89 | 5 | 37712758 | ||
| Pubmed | 2.44e-11 | 10 | 89 | 5 | 37877672 | ||
| Pubmed | 2.44e-11 | 10 | 89 | 5 | 23869841 | ||
| Pubmed | 2.44e-11 | 10 | 89 | 5 | 38426910 | ||
| Pubmed | 2.44e-11 | 10 | 89 | 5 | 37715782 | ||
| Pubmed | 2.44e-11 | 10 | 89 | 5 | 37219526 | ||
| Pubmed | 2.44e-11 | 10 | 89 | 5 | 37966111 | ||
| Pubmed | 2.88e-10 | 15 | 89 | 5 | 38413714 | ||
| Pubmed | 4.18e-10 | 16 | 89 | 5 | 32723479 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 1705528 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 2808323 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 21088134 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 69663 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 1.39e-09 | 7 | 89 | 4 | 12459592 | |
| Pubmed | Multiple sequences related to classical histocompatibility antigens in the mouse genome. | 1.39e-09 | 7 | 89 | 4 | 6264319 | |
| Pubmed | Sequence analysis of the C3H H-2K1k gene: relationship to the H-2 loci. | 1.39e-09 | 7 | 89 | 4 | 2714856 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 10500200 | ||
| Pubmed | Structural analysis of H-2Kf and H-2Kfm1 by using H-2K locus-specific sequences. | 1.39e-09 | 7 | 89 | 4 | 2391419 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 15671142 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 14215561 | ||
| Pubmed | A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity. | 1.39e-09 | 7 | 89 | 4 | 28234229 | |
| Pubmed | Interaction of H-2Db with mutant histocompatibility gene H (KH-11) in the mouse. | 1.39e-09 | 7 | 89 | 4 | 6242891 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 17512611 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 7018573 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 2642506 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 9037062 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 1840571 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 20957233 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 11580250 | ||
| Pubmed | V beta T cell repertoire of CD8+ splenocytes selected on nonpolymorphic MHC class I molecules. | 1.39e-09 | 7 | 89 | 4 | 11086076 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 12750360 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 18416856 | ||
| Pubmed | Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. | 1.39e-09 | 7 | 89 | 4 | 20974936 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 10704462 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 22573867 | ||
| Pubmed | A novel H-2K splice form: predictions for other alternative H-2 splicing events. | 1.39e-09 | 7 | 89 | 4 | 2908875 | |
| Pubmed | Comparison of exon 5 sequences from 35 class I genes of the BALB/c mouse. | 1.39e-09 | 7 | 89 | 4 | 2584927 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 3496275 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 12147629 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 3458188 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 19462379 | ||
| Pubmed | Structural diversity of the classical H-2 genes: K, D, and L. | 1.39e-09 | 7 | 89 | 4 | 1730883 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 3680952 | ||
| Pubmed | Thymus leukemia antigen controls intraepithelial lymphocyte function and inflammatory bowel disease. | 1.39e-09 | 7 | 89 | 4 | 19004778 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 6300887 | ||
| Pubmed | H-2-linked regulation of xenotropic murine leukemia virus expression. | 1.39e-09 | 7 | 89 | 4 | 6300850 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 8500526 | ||
| Pubmed | cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. | 1.39e-09 | 7 | 89 | 4 | 6265910 | |
| Pubmed | Cutting edge: MHC class I-Ly49 interaction regulates neuronal function. | 1.39e-09 | 7 | 89 | 4 | 18453559 | |
| Pubmed | DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17. | 1.39e-09 | 7 | 89 | 4 | 2906539 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 3013627 | ||
| Pubmed | DNA sequence of the mouse H-2Dd transplantation antigen gene. | 1.39e-09 | 7 | 89 | 4 | 3856254 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 3894562 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 27385590 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 1348042 | ||
| Pubmed | H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. | 1.39e-09 | 7 | 89 | 4 | 19346486 | |
| Pubmed | Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. | 1.39e-09 | 7 | 89 | 4 | 18383043 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 16272298 | ||
| Pubmed | Tissue-specific expression of an unusual H-2 (class I)-related gene. | 1.39e-09 | 7 | 89 | 4 | 6956903 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 8833240 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 21178009 | ||
| Pubmed | Expression and function of transplantation antigens with altered or deleted cytoplasmic domains. | 1.39e-09 | 7 | 89 | 4 | 6604582 | |
| Pubmed | Isolation of a cDNA clone for the murine transplantation antigen H-2Kb. | 1.39e-09 | 7 | 89 | 4 | 6954478 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 34525366 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 3374494 | ||
| Pubmed | Extensive deletions in the Q region of the mouse major histocompatibility complex. | 1.39e-09 | 7 | 89 | 4 | 3025084 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 2543831 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 2989712 | ||
| Pubmed | Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1. | 1.39e-09 | 7 | 89 | 4 | 1280760 | |
| Pubmed | Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes. | 1.39e-09 | 7 | 89 | 4 | 6786753 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 6583704 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 6571712 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 9222352 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 12006653 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 1699529 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 17982076 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 7520098 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 15644207 | ||
| Pubmed | How a single T cell receptor recognizes both self and foreign MHC. | 1.39e-09 | 7 | 89 | 4 | 17418792 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 9185075 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 21483793 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 10452993 | ||
| Pubmed | Intestinal epithelial cells modulate CD4 T cell responses via the thymus leukemia antigen. | 1.39e-09 | 7 | 89 | 4 | 21900182 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 15272181 | ||
| Pubmed | Genetic control of scrapie and Creutzfeldt-Jakob disease in mice. | 1.39e-09 | 7 | 89 | 4 | 6408182 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 26714929 | ||
| Pubmed | Partial nucleotide sequence of H-2Dd major histocompatibility antigen gene. | 1.39e-09 | 7 | 89 | 4 | 3925012 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 6280871 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 10799615 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 10993729 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 1339405 | ||
| Pubmed | H-2D(b-/-) mice are susceptible to persistent infection by Theiler's virus. | 1.39e-09 | 7 | 89 | 4 | 10823851 | |
| Pubmed | MHC class I Dk locus and Ly49G2+ NK cells confer H-2k resistance to murine cytomegalovirus. | 1.39e-09 | 7 | 89 | 4 | 19454713 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 10229092 | ||
| Pubmed | Comparison of nucleotide sequences of mRNAs belonging to the mouse H-2 multigene family. | 1.39e-09 | 7 | 89 | 4 | 6278432 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 7295646 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 2879284 | ||
| Pubmed | Structure and expression of a mouse major histocompatibility antigen gene, H-2Ld. | 1.39e-09 | 7 | 89 | 4 | 6952248 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 24064213 | ||
| Pubmed | Developmental Sculpting of Intracortical Circuits by MHC Class I H2-Db and H2-Kb. | 1.39e-09 | 7 | 89 | 4 | 25316337 | |
| Interaction | LILRB1 interactions | 8.51e-06 | 10 | 85 | 3 | int:LILRB1 | |
| Interaction | LILRB2 interactions | 8.51e-06 | 10 | 85 | 3 | int:LILRB2 | |
| Interaction | TAPBP interactions | 9.32e-06 | 67 | 85 | 5 | int:TAPBP | |
| Interaction | TOP3B interactions | NUDT19 PCNX2 GADD45B SPHK2 CTC1 ATP13A1 MTOR PLA2G4B MCM3AP AOC2 GEMIN5 PRKDC GRIN2D DENND5A MLXIP ZNF236 TMEM127 NOD2 | 3.37e-05 | 1470 | 85 | 18 | int:TOP3B |
| Interaction | HLA-H interactions | 4.72e-05 | 17 | 85 | 3 | int:HLA-H | |
| Cytoband | 16p13.3 | 8.52e-06 | 244 | 89 | 6 | 16p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 1.87e-04 | 426 | 89 | 6 | chr16p13 | |
| Cytoband | 19q13.33 | 1.18e-03 | 106 | 89 | 3 | 19q13.33 | |
| Cytoband | 14q32.12 | 1.46e-03 | 29 | 89 | 2 | 14q32.12 | |
| Cytoband | 6p21.3 | 1.46e-03 | 250 | 89 | 4 | 6p21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 2.23e-03 | 1192 | 89 | 8 | chr19q13 | |
| GeneFamily | Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases | 2.60e-06 | 9 | 58 | 3 | 90 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 1.18e-05 | 44 | 58 | 4 | 588 | |
| GeneFamily | Kallikreins | 1.70e-05 | 16 | 58 | 3 | 616 | |
| GeneFamily | C1-set domain containing | 3.29e-04 | 42 | 58 | 3 | 591 | |
| GeneFamily | Proteases, serine | 1.09e-03 | 63 | 58 | 3 | 738 | |
| GeneFamily | Phosphodiesterases | 2.67e-03 | 24 | 58 | 2 | 681 | |
| Coexpression | HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN | 7.67e-09 | 44 | 88 | 6 | MM805 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING | 6.03e-08 | 31 | 88 | 5 | MM3729 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 2.00e-07 | 39 | 88 | 5 | MM3758 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 2.09e-07 | 16 | 88 | 4 | MM3766 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP | 3.97e-07 | 84 | 88 | 6 | MM1049 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 4.42e-07 | 19 | 88 | 4 | MM797 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 4.42e-07 | 19 | 88 | 4 | MM862 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 5.52e-07 | 20 | 88 | 4 | MM3682 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 6.80e-07 | 21 | 88 | 4 | MM651 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 1.20e-06 | 24 | 88 | 4 | MM3773 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING | 1.39e-06 | 57 | 88 | 5 | MM3716 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 1.42e-06 | 25 | 88 | 4 | MM672 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_DISTAL_CONVOLUTED_TUBULE_EPITHELIAL_CELL_AGEING | 3.92e-06 | 124 | 88 | 6 | MM3726 | |
| Coexpression | GSE3982_NKCELL_VS_TH2_UP | 4.62e-06 | 197 | 88 | 7 | M5596 | |
| Coexpression | PAL_PRMT5_TARGETS_DN | 5.74e-06 | 35 | 88 | 4 | MM674 | |
| Coexpression | HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN | 8.02e-06 | 38 | 88 | 4 | M10487 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING | 8.92e-06 | 39 | 88 | 4 | MM3725 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | ARHGAP4 SPHK2 UBA7 MAN2C1 LRP10 CTC1 ATP13A1 PLA2G4B ADAM15 MCM3AP DEF8 MAU2 RNF115 | 9.97e-06 | 905 | 88 | 13 | M40865 |
| Coexpression | HOWLIN_CITED1_TARGETS_1_UP | 1.09e-05 | 41 | 88 | 4 | MM710 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 1.13e-05 | 87 | 88 | 5 | MM652 | |
| Coexpression | HU_GENOTOXIC_DAMAGE_4HR | 1.32e-05 | 43 | 88 | 4 | MM1204 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING | 1.45e-05 | 44 | 88 | 4 | MM3775 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING | 1.74e-05 | 46 | 88 | 4 | MM3712 | |
| Coexpression | GSE6269_FLU_VS_E_COLI_INF_PBMC_UP | 1.94e-05 | 164 | 88 | 6 | M5653 | |
| Coexpression | BAUS_TFF2_TARGETS_UP | 2.24e-05 | 49 | 88 | 4 | MM1287 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 2.43e-05 | 50 | 88 | 4 | MM3805 | |
| Coexpression | MARTENS_TRETINOIN_RESPONSE_UP | PRSS29P SLC34A1 AVPR2 GZMM GRB7 KLK12 PAX4 CTSD ATP4A PRIMA1 CHST8 OTOG | 2.84e-05 | 855 | 88 | 12 | M2098 |
| Coexpression | TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING | 2.84e-05 | 52 | 88 | 4 | MM3808 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 3.81e-05 | 56 | 88 | 4 | MM3852 | |
| Coexpression | CUI_DEVELOPING_HEART_C8_MACROPHAGE | 3.99e-05 | 275 | 88 | 7 | M39305 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_INTERNEURON_AGEING | 4.69e-05 | 59 | 88 | 4 | MM3688 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOCARDIAL_CELL_AGEING | 4.69e-05 | 59 | 88 | 4 | MM3704 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_16P13_AMPLICON | 5.14e-05 | 119 | 88 | 5 | M1788 | |
| Coexpression | GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_DN | 5.22e-05 | 287 | 88 | 7 | M40958 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_VENTRICULAR_MYOCYTE_AGEING | 5.35e-05 | 120 | 88 | 5 | MM3710 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP | 5.90e-05 | 200 | 88 | 6 | M4021 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP | 6.46e-05 | 64 | 88 | 4 | M1887 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_VALVE_CELL_AGEING | 6.75e-05 | 126 | 88 | 5 | MM3709 | |
| Coexpression | MA_RAT_AGING_UP | 7.01e-05 | 127 | 88 | 5 | MM16096 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE | 7.93e-05 | 211 | 88 | 6 | MM17081 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SKELETAL_MUSCLE_SATELLITE_CELL_AGEING | 9.69e-05 | 136 | 88 | 5 | MM3747 | |
| Coexpression | COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN | 1.04e-04 | 138 | 88 | 5 | M19245 | |
| Coexpression | GAURNIER_PSMD4_TARGETS | 1.08e-04 | 73 | 88 | 4 | M11428 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOTHELIAL_CELL_OF_CORONARY_ARTERY_AGEING | 1.11e-04 | 140 | 88 | 5 | MM3705 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_GRANULOCYTE_AGEING | 1.14e-04 | 74 | 88 | 4 | MM3796 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD4_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 1.19e-04 | 142 | 88 | 5 | MM3757 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_NK_CELL_AGEING | 1.20e-04 | 75 | 88 | 4 | MM3759 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING | 1.20e-04 | 75 | 88 | 4 | MM3718 | |
| Coexpression | KIM_LRRC3B_TARGETS | 1.39e-04 | 30 | 88 | 3 | M17363 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE | 1.44e-04 | 148 | 88 | 5 | M39021 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_LOOP_OF_HENLE_THICK_ASCENDING_LIMB_EPITHELIAL_CELL_AGEING | 1.53e-04 | 238 | 88 | 6 | MM3728 | |
| Coexpression | GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP | 1.58e-04 | 151 | 88 | 5 | M421 | |
| Coexpression | KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN | 1.66e-04 | 6 | 88 | 2 | M7182 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING | 1.70e-04 | 82 | 88 | 4 | MM3777 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_MACROPHAGE_AGEING | 1.70e-04 | 82 | 88 | 4 | MM3858 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOTHELIAL_CELL_OF_CORONARY_ARTERY_AGEING | 1.83e-04 | 246 | 88 | 6 | MM3713 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_BRONCHIAL_SMOOTH_MUSCLE_CELL_AGEING | 1.84e-04 | 156 | 88 | 5 | MM3763 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_NK_CELLS | 1.86e-04 | 84 | 88 | 4 | M39287 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_BASAL_CELL_OF_EPIDERMIS_AGEING | 1.96e-04 | 158 | 88 | 5 | MM3851 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 | 2.04e-04 | 86 | 88 | 4 | MM834 | |
| Coexpression | CASTELLANO_NRAS_TARGETS_UP | 2.23e-04 | 88 | 88 | 4 | MM1087 | |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP | 2.26e-04 | 616 | 88 | 9 | MM977 | |
| Coexpression | COATES_MACROPHAGE_M1_VS_M2_DN | 2.43e-04 | 90 | 88 | 4 | MM750 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_B_CELL_AGEING | 2.43e-04 | 90 | 88 | 4 | MM3756 | |
| Coexpression | JIANG_MELANOMA_TRM10_LAMINA_PROPRIA | 2.54e-04 | 91 | 88 | 4 | M48974 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_FENESTRATED_CELL_AGEING | 2.54e-04 | 91 | 88 | 4 | MM3720 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SMOOTH_MUSCLE_CELL_AGEING | 2.65e-04 | 92 | 88 | 4 | MM3748 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 2.76e-04 | 93 | 88 | 4 | MM1185 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_NK_CELL_AGEING | 3.11e-04 | 96 | 88 | 4 | MM3834 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING | 3.24e-04 | 97 | 88 | 4 | MM3789 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_OVERLAP_UP | 3.37e-04 | 98 | 88 | 4 | MM460 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_RENCA_UP | 3.64e-04 | 100 | 88 | 4 | MM458 | |
| Coexpression | GOLDRATH_ANTIGEN_RESPONSE | 3.84e-04 | 397 | 88 | 7 | MM1255 | |
| Coexpression | AFFAR_YY1_TARGETS_DN | 3.88e-04 | 283 | 88 | 6 | MM1157 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 4.07e-04 | 103 | 88 | 4 | MM476 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_PROMONOCYTE_AGEING | 4.22e-04 | 104 | 88 | 4 | MM3812 | |
| Coexpression | ZHANG_UTERUS_C5_MACROPHAGE | 4.25e-04 | 187 | 88 | 5 | MM16611 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 4.25e-04 | 187 | 88 | 5 | MM3833 | |
| Coexpression | DESCARTES_ORGANOGENESIS_HEPATOCYTES | 4.40e-04 | 535 | 88 | 8 | MM3635 | |
| Coexpression | GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP | 4.91e-04 | 193 | 88 | 5 | M3484 | |
| Coexpression | BCAT_BILD_ET_AL_DN | 5.00e-04 | 46 | 88 | 3 | M2702 | |
| Coexpression | DURAND_STROMA_NS_UP | 5.03e-04 | 194 | 88 | 5 | MM962 | |
| Coexpression | GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_DN | 5.14e-04 | 195 | 88 | 5 | M5396 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_MESENCHYMAL_STEM_CELL_AGEING | 5.27e-04 | 196 | 88 | 5 | MM3746 | |
| Coexpression | GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN | 5.39e-04 | 197 | 88 | 5 | M5760 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_B_CELL_AGEING | 5.40e-04 | 111 | 88 | 4 | MM3831 | |
| Coexpression | GSE3982_MAC_VS_NKCELL_DN | 5.51e-04 | 198 | 88 | 5 | M5509 | |
| Coexpression | GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_UP | 5.64e-04 | 199 | 88 | 5 | M9430 | |
| Coexpression | GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_UP | 5.64e-04 | 199 | 88 | 5 | M9038 | |
| Coexpression | GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_DN | 5.77e-04 | 200 | 88 | 5 | M5832 | |
| Coexpression | GSE24574_NAIVE_VS_TCONV_CD4_TCELL_UP | 5.77e-04 | 200 | 88 | 5 | M8328 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_UP | 5.77e-04 | 200 | 88 | 5 | M4050 | |
| Coexpression | GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN | 5.77e-04 | 200 | 88 | 5 | M9576 | |
| Coexpression | GSE27786_LSK_VS_NEUTROPHIL_DN | 5.77e-04 | 200 | 88 | 5 | M4761 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN | 5.77e-04 | 200 | 88 | 5 | M3638 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN | 5.77e-04 | 200 | 88 | 5 | M3635 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP | 5.77e-04 | 200 | 88 | 5 | M4966 | |
| Coexpression | KAECH_NAIVE_VS_MEMORY_CD8_TCELL_DN | 5.77e-04 | 200 | 88 | 5 | M3022 | |
| Coexpression | KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_DN | 5.77e-04 | 200 | 88 | 5 | M3017 | |
| Coexpression | ZHANG_UTERUS_C9_DENDRITIC_CELL | 5.97e-04 | 114 | 88 | 4 | MM16615 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.03e-07 | 153 | 88 | 6 | ce7a23c687e9e7d83d244046de19c854caded09b | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-06 | 172 | 88 | 6 | da959c1abadafd79b7a0088a25eb8ef8efa3a0c2 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 178 | 88 | 6 | 09d2687e0d79f12e90af35fc1c0453d249cf2d19 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-06 | 185 | 88 | 6 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-06 | 188 | 88 | 6 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-06 | 194 | 88 | 6 | 9116451614431e3cf9bd7d4d626bf4bd23420e36 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-06 | 194 | 88 | 6 | bf7bf75bbc2035be25d3605e6a1a59e6bc573be7 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK|blood / Manually curated celltypes from each tissue | 2.48e-06 | 195 | 88 | 6 | 731a454e45c7b610e0140312bcabaea711dcc766 | |
| ToppCell | BLOOD--(0)_NK_cell| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.63e-06 | 197 | 88 | 6 | ce35c3ba6db897235d0107fa7dadc5013bf4da24 | |
| ToppCell | BLOOD--(0)_NK_cells_(CD56dim-like)| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.63e-06 | 197 | 88 | 6 | 4c15b3386b89191af9332738e597549e2305de26 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.63e-06 | 197 | 88 | 6 | c7cd7960e8f022b1db49485ff153675827efa35e | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.70e-06 | 198 | 88 | 6 | 0dc4a564dcab8ac42f238f98ee1f2090b0dcffe6 | |
| ToppCell | Caecum-T_cell-CD8_T|T_cell / Region, Cell class and subclass | 2.86e-06 | 200 | 88 | 6 | 40e435f5dd1a0f6554f87dc1e170a740fd733d5b | |
| ToppCell | Sigmoid-T_cell-CD8_T|T_cell / Region, Cell class and subclass | 2.86e-06 | 200 | 88 | 6 | 2071a71b6fba403f55becddc0434d56a0b598c8e | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Radial_glial-RG|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.86e-06 | 200 | 88 | 6 | fb7c9c0e4beadad6e41e68f6f889e56650898d22 | |
| ToppCell | LAM-Lymphoid-NK|Lymphoid / Condition, Lineage and Cell class | 2.86e-06 | 200 | 88 | 6 | cd2169b09626aa6257fd7cb3f951fcbe7c59f88c | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Radial_glial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.86e-06 | 200 | 88 | 6 | fff209256805a448393c385b79a70c2e2172e49c | |
| ToppCell | BLOOD--(0)_NK_cell-(0)_NK_cells_(CD56dim-like)|(0)_NK_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.02e-05 | 145 | 88 | 5 | 6dd81d53d006fcc206a10969374a11c372f92133 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.25e-05 | 151 | 88 | 5 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-05 | 156 | 88 | 5 | 25b0936960be4955b6a6d6b8a867fdd4be548f05 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-05 | 161 | 88 | 5 | b60b4fd34a3ad4bf1813e6cc24aa7e04f9e53e4c | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.40e-05 | 173 | 88 | 5 | 1e8a43ff32eab95857c794e0bf4f0b0dba155b4a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 173 | 88 | 5 | 0ba64e5385fe714f876002520f8b5202809bf11e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 175 | 88 | 5 | b9931455f232de3029510993015bb13b70dc18c9 | |
| ToppCell | IIF-Lymphocyte-T_NK-gdT|IIF / Disease, Lineage and Cell Type | 2.75e-05 | 178 | 88 | 5 | 3344d1328fd9c570c3a4b2629edec627a442d0e0 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.83e-05 | 179 | 88 | 5 | df4d0b2fe47d2c7def729b3217cb01ced01495ff | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.14e-05 | 183 | 88 | 5 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | COVID-19_Severe-CD4+_CTL|COVID-19_Severe / Disease condition and Cell class | 3.40e-05 | 186 | 88 | 5 | 728d81405fdcd137097433dd676b26519185e916 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_C|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.48e-05 | 187 | 88 | 5 | 1e8651e6c547384ace5a66b96c6b24a7f390a7ee | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Cytotoxic_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.57e-05 | 188 | 88 | 5 | c80956649b10b7dd7540394a00fc2a0619b27e80 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.57e-05 | 188 | 88 | 5 | a29c43a91ed1364a09d5abab6efa51b8061bce74 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-SELL+_CD4_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.66e-05 | 189 | 88 | 5 | 5c92516c3745ccbd480b15bb2b9077ab1d9ee5a0 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.76e-05 | 190 | 88 | 5 | 5f1863bce9400b7c932f0e4d0e012ec4e8d7e555 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-SELL+_CD8_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.76e-05 | 190 | 88 | 5 | d83fdc352ebb0c2f2a7c2138bf6e3b7a8ce83a6a | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.85e-05 | 191 | 88 | 5 | 47156e5f1d790707f42f6283104a44b33af613e5 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.85e-05 | 191 | 88 | 5 | 2ad34ccd55362db04511c90cf264ae5b93b48dde | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.85e-05 | 191 | 88 | 5 | 2bd4ba4aaa0f4885079516156b409df527ab22f4 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-NK|normal_Pleural_Fluid / Location, Cell class and cell subclass | 3.95e-05 | 192 | 88 | 5 | 59dd4f5ae9f1cca78adf60b71661092ef09e6641 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.95e-05 | 192 | 88 | 5 | 7460ce6e2f91bbf940b684f63231db7501ace09f | |
| ToppCell | T/NK_cells-CD56bright_NK_cell|World / Lineage and Cell class | 3.95e-05 | 192 | 88 | 5 | 528b5b790a0e8966d04ffbc83b049c93bac17537 | |
| ToppCell | ILEUM-non-inflamed-(1)_Cytotoxic_CD8_Trm|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.95e-05 | 192 | 88 | 5 | cc9287803cd979e4b81f0649527f1b3bf54d0b83 | |
| ToppCell | T/NK_cells-CD8+_Effector_T_cell|World / Lineage and Cell class | 4.05e-05 | 193 | 88 | 5 | 79fa0f482cd98642b1d38835cda98622f21e5bd0 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 4.05e-05 | 193 | 88 | 5 | e325cf49e159c6be205ed93adaa09efdd0c122b4 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMH+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.05e-05 | 193 | 88 | 5 | d66cbb8c71bdc57faecb74a16fe3f34cb0b33228 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.05e-05 | 193 | 88 | 5 | c1d9c2436503791350086a503d6b98c5c69f44ae | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.05e-05 | 193 | 88 | 5 | fce4f805e53669acb4c188f87ac7d84408c0c218 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.05e-05 | 193 | 88 | 5 | 6e1498153a7766c03fddbda1701dbf1596d21736 | |
| ToppCell | Healthy_donor-CD8+_Tem|Healthy_donor / disease group, cell group and cell class (v2) | 4.15e-05 | 194 | 88 | 5 | bf2e889de60b2b452a41f4d59a0f2a1865f07184 | |
| ToppCell | lymphoid-NK_cell-NK_cell|World / Lineage, cell class and subclass | 4.15e-05 | 194 | 88 | 5 | 7f5adc18e632109694446b8eb1543cbae62dccbe | |
| ToppCell | normal-na-Lymphocytic_NK-NK_bright-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.15e-05 | 194 | 88 | 5 | dc4aeee379423827e8d291cffe4dbdf2ff6d0bbe | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD4+_Th|normal_Lymph_Node / Location, Cell class and cell subclass | 4.15e-05 | 194 | 88 | 5 | 208b56b2a1f5494b74f9423f2bdc2eb6d6023fa9 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_bright|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.15e-05 | 194 | 88 | 5 | 8c5f716ce05c1f187de63c1b6948eb9f90ff34fe | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.15e-05 | 194 | 88 | 5 | 95ab357d5f7bf91ba287417928c8575e655814fc | |
| ToppCell | Monocytes-Phagocytic_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 4.15e-05 | 194 | 88 | 5 | 40dbfdf1d7e6b73d120d8f802f08e573fe9a739e | |
| ToppCell | (1)_T_cells-(1)_T_CD8_activated|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.15e-05 | 194 | 88 | 5 | e3f288b58525c1f34db4459d3e83e0df695adfc7 | |
| ToppCell | lymphoid-NK_cell|World / Lineage, cell class and subclass | 4.15e-05 | 194 | 88 | 5 | 4bf5a140be8691e4ec99d7ee15588fd48acd6fb5 | |
| ToppCell | IIF-Lymphocyte-T_NK-NK|IIF / Disease, Lineage and Cell Type | 4.25e-05 | 195 | 88 | 5 | 464ce05cb52f78aee22d3baa6641b37bd53aae16 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.25e-05 | 195 | 88 | 5 | 1af6fd96634236d5910fd085ff2d532862303d6b | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue | 4.25e-05 | 195 | 88 | 5 | 789149fb52d9d16393e1649358515add60d37f2d | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.25e-05 | 195 | 88 | 5 | ed41e709523cc3b86b1090d4fc0938ed47cb1fc9 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.25e-05 | 195 | 88 | 5 | 72f42f0be53a2a61f61647118b4883e752d998a5 | |
| ToppCell | 10x5'-blood-Lymphocytic_NK|blood / Manually curated celltypes from each tissue | 4.25e-05 | 195 | 88 | 5 | c1db871e8e8e8b8d6a5798bc43eaf54e102b75eb | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.25e-05 | 195 | 88 | 5 | 49a4f58aac168fc1838bd5d2b202135cd794c28b | |
| ToppCell | T/NK_cells-CD8+_Effector_T_cell|T/NK_cells / Lineage and Cell class | 4.25e-05 | 195 | 88 | 5 | 9bb1281e63daf6aca2817f9cc1f55463b069909f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-SELL+_CD4_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.25e-05 | 195 | 88 | 5 | 8687b319f1f487fbef4ca075fad054751a641de6 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD16|lymph-node_spleen / Manually curated celltypes from each tissue | 4.25e-05 | 195 | 88 | 5 | e756733cf48768bf40058d6cf9039e52f7563133 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.25e-05 | 195 | 88 | 5 | 1a7c2c4cf30df435770794a989be438579bf98f2 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.36e-05 | 196 | 88 | 5 | ab6022041c33617bca3ed0c62f19673cd2750da9 | |
| ToppCell | severe-CD8+_Tem|World / disease stage, cell group and cell class | 4.36e-05 | 196 | 88 | 5 | b8156d31312660fe9c071cb10d7ef22af672c6c8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.36e-05 | 196 | 88 | 5 | ff88e5b919b1be93159ad2200a7786d1c5272724 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 4.36e-05 | 196 | 88 | 5 | 1868ad537b7f04cdad0a0c8282aadbc4f257a722 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.46e-05 | 197 | 88 | 5 | 76304df40f87224f8e415677e3ee8fb183fe0c03 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-APOE+_Mac1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.46e-05 | 197 | 88 | 5 | 121ec3f6d978de2f6c2cc397f7327d2e5587ab8b | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-NK|T/NK_cells / Location, Cell class and cell subclass | 4.46e-05 | 197 | 88 | 5 | 52e6b772f8c3a623b1b0c28119918fb9935803e1 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 4.46e-05 | 197 | 88 | 5 | 2bf540fa228687a71f595a807e4a2af20588a82c | |
| ToppCell | Healthy-CD8+_Tem|Healthy / disease group, cell group and cell class | 4.46e-05 | 197 | 88 | 5 | 8d60fdd5ce80c3496637fd3257d25258df6d7f75 | |
| ToppCell | 343B-Lymphocytic-NK_cells|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.46e-05 | 197 | 88 | 5 | e1009fa54d365a7f4345fef836da6076b5c1c3d0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-Activated_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.46e-05 | 197 | 88 | 5 | dfec2afd1cbe218c9234ce7d4b5a5839b268398d | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.57e-05 | 198 | 88 | 5 | 5f465cf5c7493e32d9afe9e9d05757d0a95acc33 | |
| ToppCell | Transverse-T_cell-CD8_T|T_cell / Region, Cell class and subclass | 4.57e-05 | 198 | 88 | 5 | 3b0613171cc7d5320f0b525cc6836f21874b0505 | |
| ToppCell | (2)_NK/T-(20)_NK_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 4.57e-05 | 198 | 88 | 5 | 2e4851e49457940e841660c5d781499ffb4a2bf1 | |
| ToppCell | mild-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.57e-05 | 198 | 88 | 5 | 1d20fc9948965de52a98f758035edfdd12cafc5f | |
| ToppCell | (0)_NK_FCGR3Apos|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.57e-05 | 198 | 88 | 5 | 13f10f9233fc1523f0da2d9d59f3ced9c51a603a | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-NK|Multiple_Sclerosis / Disease, Lineage and Cell Type | 4.57e-05 | 198 | 88 | 5 | d413020012977eb8da0a5641dd16d0b0a60bec38 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.57e-05 | 198 | 88 | 5 | 77ce3fe1ab161c0faf8987e73a64ab61294b9255 | |
| ToppCell | wk_20-22|World / Celltypes from embryonic and fetal-stage human lung | 4.57e-05 | 198 | 88 | 5 | 56eb765773a1a27a44262a447df7cfae8a9db90d | |
| ToppCell | 390C-Lymphocytic-NK_cells|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.57e-05 | 198 | 88 | 5 | 872ddb2738c5e0375830bb0e5b2c50383bf58738 | |
| ToppCell | (2)_NK/T-(200)_CD56+_NK_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 4.57e-05 | 198 | 88 | 5 | 03477a6356a3c08c6e723165c0aac3464ef01667 | |
| ToppCell | (0)_NK_cells|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.57e-05 | 198 | 88 | 5 | c91c3ccba118dffb12c0bf8036f51fc76f0e305d | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-gd_T|IIF / Disease, condition lineage and cell class | 4.68e-05 | 199 | 88 | 5 | 2c0e981839c256d76fa049532c8d49f31ce9bfee | |
| ToppCell | cellseq2-Immune|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.68e-05 | 199 | 88 | 5 | 631f29931d102ea308088809a05281588c9c9e3d | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-NK|T/NK_cells / Location, Cell class and cell subclass | 4.68e-05 | 199 | 88 | 5 | 4e7be837fd23934a338864380fa24b00db007358 | |
| ToppCell | 356C-Lymphocytic-NK_cells|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.68e-05 | 199 | 88 | 5 | 9c196c3d8260379d3c9711179e0a913ac9906438 | |
| ToppCell | (1)_T_cell-(10)_CD8_T|(1)_T_cell / shred on Cell_type and subtype | 4.68e-05 | 199 | 88 | 5 | d04896156e9ef6dda5f4f69fefdc7038c617d969 | |
| ToppCell | Control-NK|Control / Disease condition and Cell class | 4.68e-05 | 199 | 88 | 5 | f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650 | |
| ToppCell | 5'-GW_trimst-2-LymphNode|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.68e-05 | 199 | 88 | 5 | 4a9ca133125dc25a06e7b1cfea15ecffa449c20e | |
| ToppCell | lymphoid-T_cell-CD8+_Naive_T_cell|T_cell / Lineage, cell class and subclass | 4.68e-05 | 199 | 88 | 5 | 9ee40563e840a7fe97e7592539d42e19db438c64 | |
| ToppCell | mild_COVID-19-NK|mild_COVID-19 / disease group, cell group and cell class (v2) | 4.68e-05 | 199 | 88 | 5 | 4854f25ee436e1cf577744373ffd87b1221d2b88 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.68e-05 | 199 | 88 | 5 | c3ee60602bdb166a5e67ba1c884dba88b934dfe1 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.68e-05 | 199 | 88 | 5 | da20998253ad08a4a127a98b991b26237edb61a2 | |
| Computational | Genes in the cancer module 293. | 1.37e-05 | 12 | 44 | 3 | MODULE_293 | |
| Computational | Genes in the cancer module 143. | 2.26e-05 | 14 | 44 | 3 | MODULE_143 | |
| Computational | Neighborhood of PTPRC | 1.64e-04 | 68 | 44 | 4 | GNF2_PTPRC | |
| Computational | Neighborhood of CD48 | 2.92e-04 | 32 | 44 | 3 | GNF2_CD48 | |
| Computational | Neighborhood of INPP5D | 7.04e-04 | 43 | 44 | 3 | GNF2_INPP5D | |
| Computational | Neighborhood of HLA-C | 9.15e-04 | 47 | 44 | 3 | GNF2_HLA_C | |
| Computational | Neighborhood of PTPN6 | 9.15e-04 | 47 | 44 | 3 | GNF2_PTPN6 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.10e-03 | 50 | 44 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_V_ATPASE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.10e-03 | 50 | 44 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.10e-03 | 50 | 44 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_INTERFERON_MHC | |
| Computational | Neighborhood of CD53 | 1.69e-03 | 58 | 44 | 3 | GNF2_CD53 | |
| Drug | AC1L3S1M | 4.60e-07 | 41 | 86 | 5 | CID000121071 | |
| Drug | phenylmethylsulfonyl fluoride | 6.76e-07 | 263 | 86 | 9 | CID000004784 | |
| Drug | A80a | 8.78e-07 | 20 | 86 | 4 | CID005487000 | |
| Drug | B3852 | 1.32e-06 | 22 | 86 | 4 | CID003081658 | |
| Drug | TLCK | 2.30e-06 | 158 | 86 | 7 | CID000004427 | |
| Drug | diisopropylfluorophosphate | 3.49e-06 | 321 | 86 | 9 | CID000005936 | |
| Drug | T-kinin | 1.73e-05 | 41 | 86 | 4 | CID000123643 | |
| Drug | camostate | 2.09e-05 | 88 | 86 | 5 | CID000002536 | |
| Drug | AC1L1FCN | 2.29e-05 | 15 | 86 | 3 | CID000003178 | |
| Drug | AGN-1133 | 2.74e-05 | 93 | 86 | 5 | CID000015178 | |
| Drug | chlorazanil | 2.81e-05 | 16 | 86 | 3 | CID000010374 | |
| Drug | AC1NRA8H | 3.03e-05 | 95 | 86 | 5 | CID005287756 | |
| Drug | methylimidazoleacetic acid | 3.41e-05 | 17 | 86 | 3 | CID000075810 | |
| Drug | 2D7 | 3.53e-05 | 49 | 86 | 4 | CID005327103 | |
| Drug | thymidine glycol monophosphate | 4.22e-05 | 3 | 86 | 2 | CID000165415 | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 7.45e-07 | 7 | 83 | 3 | DOID:0081267 (implicated_via_orthology) | |
| Disease | tryptase beta-2 measurement | 1.78e-06 | 9 | 83 | 3 | EFO_0008306 | |
| Disease | beta-2 microglobulin measurement | 3.48e-06 | 11 | 83 | 3 | EFO_0005197 | |
| Disease | – | 7.82e-06 | 2 | 83 | 2 | 608579 | |
| Disease | Susceptibility to severe cutaneous adverse reaction | 7.82e-06 | 2 | 83 | 2 | cv:C1840548 | |
| Disease | Carbamazepine response | 7.82e-06 | 2 | 83 | 2 | cv:CN077964 | |
| Disease | LDL cholesterol change measurement, response to fenofibrate | 2.34e-05 | 3 | 83 | 2 | EFO_0007804, GO_1901557 | |
| Disease | Stevens-Johnson syndrome (is_implicated_in) | 4.67e-05 | 4 | 83 | 2 | DOID:0050426 (is_implicated_in) | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 7.44e-05 | 29 | 83 | 3 | C1274933 | |
| Disease | Toxic Epidermal Necrolysis | 7.44e-05 | 29 | 83 | 3 | C0014518 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 7.44e-05 | 29 | 83 | 3 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 7.44e-05 | 29 | 83 | 3 | C3658302 | |
| Disease | allergic asthma (is_implicated_in) | 7.77e-05 | 5 | 83 | 2 | DOID:9415 (is_implicated_in) | |
| Disease | Stevens-Johnson Syndrome | 8.25e-05 | 30 | 83 | 3 | C0038325 | |
| Disease | Malignant neoplasm of breast | KLK15 DAP3 MAN2C1 AVPR2 MTOR ZSWIM5 TMPRSS6 SREBF2 GRB7 GRIN2D RNF115 | 2.07e-04 | 1074 | 83 | 11 | C0006142 |
| Disease | ureteral obstruction (biomarker_via_orthology) | 2.80e-04 | 45 | 83 | 3 | DOID:5199 (biomarker_via_orthology) | |
| Disease | end stage renal disease (biomarker_via_orthology) | 3.18e-04 | 47 | 83 | 3 | DOID:783 (biomarker_via_orthology) | |
| Disease | thyroid gland papillary carcinoma (is_implicated_in) | 3.47e-04 | 10 | 83 | 2 | DOID:3969 (is_implicated_in) | |
| Disease | basophil count | 4.29e-04 | 483 | 83 | 7 | EFO_0005090 | |
| Disease | hypertension (implicated_via_orthology) | 4.76e-04 | 128 | 83 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | Arthritis, Psoriatic | 6.96e-04 | 14 | 83 | 2 | C0003872 | |
| Disease | Mammary Carcinoma, Human | 7.02e-04 | 525 | 83 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 7.02e-04 | 525 | 83 | 7 | C1257931 | |
| Disease | Mammary Neoplasms | 7.18e-04 | 527 | 83 | 7 | C1458155 | |
| Disease | serum IgE measurement | 7.90e-04 | 64 | 83 | 3 | EFO_0004579 | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 8.02e-04 | 15 | 83 | 2 | EFO_0801746 | |
| Disease | cathepsin D measurement | 8.02e-04 | 15 | 83 | 2 | EFO_0010611 | |
| Disease | Breast Carcinoma | 8.10e-04 | 538 | 83 | 7 | C0678222 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 8.21e-04 | 148 | 83 | 4 | C0279702 | |
| Disease | Dermatitis | 9.14e-04 | 16 | 83 | 2 | C0011603 | |
| Disease | Malignant Glioma | 1.03e-03 | 70 | 83 | 3 | C0555198 | |
| Disease | mixed gliomas | 1.03e-03 | 70 | 83 | 3 | C0259783 | |
| Disease | Cleft palate | 1.07e-03 | 71 | 83 | 3 | HP_0000175 | |
| Disease | urticaria | 1.44e-03 | 20 | 83 | 2 | EFO_0005531 | |
| Disease | COVID-19 (is_implicated_in) | 1.59e-03 | 21 | 83 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | complement factor H-like 1 protein measurement | 1.74e-03 | 22 | 83 | 2 | EFO_0600092 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.86e-03 | 86 | 83 | 3 | EFO_0008595, EFO_0020945 | |
| Disease | susceptibility to Mycobacterium tuberculosis infection measurement | 1.86e-03 | 86 | 83 | 3 | EFO_0008407 | |
| Disease | sciatic neuropathy (implicated_via_orthology) | 1.90e-03 | 23 | 83 | 2 | DOID:11446 (implicated_via_orthology) | |
| Disease | Glioma | 1.92e-03 | 87 | 83 | 3 | C0017638 | |
| Disease | basal cell carcinoma | 2.02e-03 | 189 | 83 | 4 | EFO_0004193 | |
| Disease | gastric carcinoma | 2.05e-03 | 89 | 83 | 3 | EFO_0000178 | |
| Disease | autism spectrum disorder, schizophrenia | 2.32e-03 | 327 | 83 | 5 | EFO_0003756, MONDO_0005090 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ASSHCLWVDEFAPRH | 276 | Q8WVB6 | |
| ITACILLLPHEAWHF | 186 | P46663 | |
| ARHCPDLCVVWVDAH | 131 | P78540 | |
| HHVAAALGLCPREWA | 1091 | Q2NKJ3 | |
| DLHLPGHTCALSWRE | 171 | Q13444 | |
| TICLAHALTVLSGHW | 106 | Q9HD20 | |
| VHPKWVLTAAHCLAQ | 56 | P51124 | |
| ILEGTASNLECHLWH | 481 | Q8IYT2 | |
| AHRPIDHWDAVNLEC | 201 | Q9UBZ4 | |
| FWGHCINALVHSLIL | 961 | Q9NTI2 | |
| HPISDHEATLRCWAL | 216 | P01893 | |
| CLRHDVDALLWQPHS | 456 | Q96RS6 | |
| LLLDHRALDPAHWTV | 241 | O75106 | |
| DWPALAVDLAHHLQV | 1251 | Q9H2M9 | |
| LASVSHPQSCHWLLD | 211 | Q7Z4F1 | |
| LCAHLDCTPDIWALH | 181 | A8MXV4 | |
| LIDHRWVLTAAHCSG | 51 | Q9UKR0 | |
| LQAVQWLVSHCPHSL | 1551 | O60318 | |
| HPLSDHEATLRCWAL | 216 | P10321 | |
| PHLLSCNAAFHLRWL | 1481 | A6NKB5 | |
| LISPHWVLSAAHCQS | 51 | Q9H2R5 | |
| WLSLECTVHINIHIP | 176 | Q5SWX8 | |
| HDLHLLAFPTKCIWI | 161 | P0CG43 | |
| VLVHPQWLLTAAHCR | 96 | Q9Y337 | |
| LWALINEALLHDEPH | 401 | P0C869 | |
| HPISDHEATLRCWAL | 216 | P01889 | |
| LHSIHSEWQERPLCE | 846 | P28290 | |
| HALSDETWGLVECHP | 136 | Q14451 | |
| ETWGLVECHPHLALE | 141 | Q14451 | |
| AGVVPDLLWAAHHAC | 256 | Q8N4S7 | |
| IISAHIHPVCSLCWS | 61 | Q15291 | |
| HGLTWHLVQEECLPS | 956 | P78509 | |
| VAWPCLDASLAHHLI | 321 | O43316 | |
| LRNHSLIQIWCHPDS | 296 | Q06495 | |
| HRTALSWLDQHCSLP | 861 | Q9HAP2 | |
| CPGIHHTEWARLALF | 411 | Q9UFP1 | |
| LIHPCWVLTAAHCTD | 351 | Q14520 | |
| DLHCLLVTNPHTDAW | 116 | O75293 | |
| CWSLVAPHLVEAACH | 1206 | Q5TH69 | |
| PSIHCKLLDIACWIH | 106 | P07339 | |
| LHHWIALLADCPITA | 1231 | Q6IQ26 | |
| HPISDHEATLRCWAL | 216 | P04439 | |
| GSHVDCWLHLSLPVQ | 981 | Q9NTJ4 | |
| SHCHWNDLAVIPARV | 306 | Q6ZN54 | |
| HHDAAPVDGRWLCVV | 81 | Q8NEP7 | |
| VIPDIPDHFLCLWEH | 121 | Q9BQA5 | |
| DHRCWVHILDNDTIP | 46 | Q6T423 | |
| HIEACSLPEHNLITW | 576 | Q9Y6X3 | |
| PLLCVGLRAQWEDHH | 891 | P20648 | |
| VICPWEAFNHLELHE | 66 | P18545 | |
| FLPGASWIADCARHH | 2776 | Q6ZRI0 | |
| GLEHLHIWISIPFCL | 21 | Q8NGK3 | |
| LIGWVPHCDTLHALI | 2236 | P42345 | |
| LILHIPDAHLWVKNC | 151 | P51398 | |
| GSLIHPQWVLTAAHC | 61 | Q15661 | |
| GSLIHPQWVLTAAHC | 61 | P20231 | |
| HSSCIVPWLELHDTC | 251 | Q9Y4L5 | |
| GSLIHPQWVLTAAHC | 101 | A6NIE9 | |
| IHPLWVITAAHCNLP | 46 | Q8IYP2 | |
| SLLLHCALHPLWGFV | 16 | Q86XR5 | |
| SIGELEIHNTCWPHL | 206 | O60811 | |
| LLSPLHCWAVLLQHT | 96 | P98171 | |
| SSELYLHCHPDILNW | 261 | Q9UNK9 | |
| IHWDHVSRLCSPCLI | 326 | Q9H2A9 | |
| TVICPWEAFSHLELH | 61 | Q13956 | |
| EDSLPKLCHAWGLHS | 161 | Q86WR6 | |
| HQRDEAGWTPLHIAC | 91 | Q86WC6 | |
| HPAINDVLWACALSH | 1036 | Q9P217 | |
| TSALHGLCHLPVFSW | 476 | Q9HC29 | |
| APHARFDDGLVHLCW | 556 | Q9NRA0 | |
| LHDPHPTCWSDLAAQ | 61 | P41226 | |
| HLITPCQQFHWDLLI | 401 | A6NJ88 | |
| HSAVPDSLRWLCHPL | 751 | Q12772 | |
| LRGHDDEIHSIAWCP | 191 | Q8TEQ6 | |
| LLLEALAWAQEHCHE | 631 | Q6NUQ4 | |
| VDDSSCQLVPHLHIW | 321 | Q8IV45 | |
| ECLPHSHDVSAWLPD | 136 | Q5T7W7 | |
| SSHALICISHWILGI | 3906 | P78527 | |
| TLHALLVSWPALARH | 796 | O60290 | |
| LWHEHVPTACARVDA | 561 | Q9HCJ5 | |
| HPAINDVLWACALSH | 1066 | Q9HCJ5 | |
| VHGPHEAFSQLWELC | 56 | O14771 | |
| LLERCWLHHDPDGVL | 6 | Q9UL36 | |
| VHACEWNPHAVVALR | 261 | Q53H54 | |
| HLNEDIFLWTLPHCQ | 101 | Q8N6G2 | |
| LEGHHQEIWCLAVSP | 671 | Q9UNX4 | |
| ITALCTALAEPAWLH | 41 | O75204 | |
| WAPIHVFIGHLCLAD | 71 | P30518 | |
| KGPDHLASSCLWHLQ | 236 | Q8IU80 | |
| LLHALSLPHGADIFW | 1031 | Q9P2D8 | |
| HPAVNDVLWACSLSH | 841 | Q9H7M6 | |
| AAWHCRHCASLELLP | 1176 | O15399 |